We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+27.08%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$5.26B
AUM Growth
+$1.49B
Cap. Flow
+$577M
Cap. Flow %
10.98%
Top 10 Hldgs %
12.35%
Holding
400
New
51
Increased
150
Reduced
100
Closed
64

Sector Composition

Rank Sector Weight
1 Technology 21.25%
2 Healthcare 18.43%
3 Financials 15.05%
4 Consumer Discretionary 13.49%
5 Industrials 11.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLE icon
201
Apple Hospitality REIT
APLE
$3.68B
$12.7M 0.24%
985,325
+270,446
+38% +$3.21M
UCB
202
United Community Banks
UCB
$4.36B
$12.6M 0.24%
442,335
+108,867
+33% +$2.57M
FCFS icon
203
FirstCash
FCFS
$9.04B
$12.6M 0.24%
179,550
-16,321
-8% -$1.03M
IOVA icon
204
Iovance Biotherapeutics
IOVA
$2.94B
$12.5M 0.24%
269,229
-101,839
-27% -$4.04M
ALEX
205
DELISTED
Alexander & Baldwin
ALEX
$12.4M 0.24%
722,113
+368,916
+104% +$5.38M
MNRO icon
206
Monro
MNRO
$365M
$12.1M 0.23%
227,801
+71,626
+46% +$3.27M
AXSM icon
207
Axsome Therapeutics
AXSM
$11.1B
$11.9M 0.23%
+146,325
New +$10.9M
FBNC icon
208
First Bancorp
FBNC
$2.7B
$11.9M 0.23%
350,299
+93,720
+37% +$2.72M
PDCO
209
DELISTED
Patterson Companies, Inc.
PDCO
$11.8M 0.22%
396,615
+165,416
+72% +$4.69M
FBK icon
210
FB Financial Corp
FBK
$3.07B
$11.7M 0.22%
337,092
+142,770
+73% +$4.49M
IRWD icon
211
Ironwood Pharmaceuticals
IRWD
$711M
$11.7M 0.22%
1,023,882
-93,149
-8% -$1.02M
DY icon
212
Dycom Industries
DY
$12.1B
$11.6M 0.22%
153,983
-36,946
-19% -$2.55M
OPLN
213
Openlane
OPLN
$4.48B
$11.6M 0.22%
623,927
-57,011
-8% -$984K
CYTK icon
214
Cytokinetics
CYTK
$10.6B
$11.5M 0.22%
+555,684
New +$10.2M
FCN icon
215
FTI Consulting
FCN
$4.22B
$11.4M 0.22%
102,280
-9,250
-8% -$996K
CLDR
216
DELISTED
Cloudera, Inc.
CLDR
$11.4M 0.22%
820,049
+6,446
+0.8% +$73.8K
EFSC icon
217
Enterprise Financial Services Corp
EFSC
$2.4B
$11.4M 0.22%
325,608
+136,208
+72% +$4.46M
OXM icon
218
Oxford Industries
OXM
$542M
$11.2M 0.21%
171,531
+84,042
+96% +$4.34M
SSB icon
219
SouthState Bank Corp
SSB
$10.7B
$11.2M 0.21%
154,928
+10,026
+7% +$659K
PGTI
220
DELISTED
PGT, Inc.
PGTI
$11M 0.21%
542,504
-49,392
-8% -$919K
LADR
221
Ladder Capital
LADR
$1.26B
$11M 0.21%
+1,127,278
New +$9.57M
SANM icon
222
Sanmina
SANM
$10.9B
$11M 0.21%
345,150
+144,007
+72% +$4.27M
SHO icon
223
Sunstone Hotel Investors
SHO
$1.98B
$11M 0.21%
+970,608
New +$9.29M
LPRO
224
DELISTED
Open Lending Corp
LPRO
$10.8M 0.21%
310,042
-65,886
-18% -$1.92M
BGS icon
225
B&G Foods
BGS
$277M
$10.6M 0.2%
381,058
+159,256
+72% +$4.49M

Similar funds

Peregrine Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Peregrine Capital Management held 400 positions worth $5.26B, up 39% from $3.77B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Peregrine Capital Management deployed $577M of net new capital in Q4 2020, opening 51 new positions and adding to 150 existing holdings. Its largest new stake was Beyond Meat: 229,246 shares worth $28.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Trade Desk, an estimated $14M trimmed.

  • Peregrine Capital Management's largest Q4 2020 buy was Beyond Meat: 229,246 shares worth $28.7M.
  • Peregrine Capital Management added most to Splunk Inc in Q4 2020, an estimated $13.5M increase.
  • Peregrine Capital Management's biggest Q4 2020 reduction was Trade Desk, cutting an estimated $14M.
  • Peregrine Capital Management fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $16.2M.
  • Peregrine Capital Management's ten largest holdings make up 12% of its $5.26B portfolio in Q4 2020.
  • Peregrine Capital Management opened 51 new positions and closed 64 in Q4 2020.
  • Peregrine Capital Management's portfolio value rose 39% quarter-over-quarter to $5.26B.

Based on Peregrine Capital Management's 13F filing for Q4 2020, filed 19 Jan 2021.